Literature DB >> 27894461

Does Mindfulness-Based Cognitive Therapy benefit all people with diabetes and comorbid emotional complaints equally? Moderators in the DiaMind trial.

Ivan Nyklíček1, Jenny van Son2, Victor J Pop2, Johan Denollet2, François Pouwer2.   

Abstract

OBJECTIVES: Research has shown the effectiveness of mindfulness-based interventions for a variety of emotional problems in different samples, but it is unknown which factors influence this effectiveness. Therefore, the aim of the current study was: which factors (demographic, personality, and baseline levels of mindfulness skills) moderate the effectiveness of Mindfulness-Based Cognitive Therapy (MBCT)?
METHODS: Outpatients with diabetes (type 1 or type 2; N=139) and an elevated level of emotional distress participated in the Diabetes and Mindfulness (DiaMind) trial. They were randomized into MBCT (N=70) or a control group (N=69) that received treatment as usual and that was offered the intervention 6months later. Primary outcomes were anxiety, depressive symptoms, and perceived stress at post-intervention and at 6-month follow-up.
RESULTS: Mixed models analyses showed that sex, extraversion, and baseline acting with awareness were significant moderators of effectiveness. In the MBCT group, women showed larger decreases in anxiety and depression across time (large effects) compared to men (medium to small effects). For extraversion divided into quartiles, the three lowest quartiles generally exhibited large decreases in symptoms, whereas the high extraversion group showed medium (perceived stress) to small (depression) decreases.
CONCLUSION: MBCT seems to be effective to decrease symptoms of anxiety, depression, and perceived stress for a broad range of person characteristics in patients with diabetes. However, men and those high in extraversion showed considerably lower effectiveness compared to the other groups. The small effect in high extraverts may be due to the large dropout in this subgroup. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Mindfulness-Based Cognitive Therapy; Moderator; Personality; Randomized trial

Mesh:

Year:  2016        PMID: 27894461     DOI: 10.1016/j.jpsychores.2016.10.009

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  5 in total

1.  Telephone-based mindfulness training to reduce stress in women with myocardial infarction: Rationale and design of a multicenter randomized controlled trial.

Authors:  Tanya M Spruill; Harmony R Reynolds; Victoria Vaughan Dickson; Amanda J Shallcross; Pallavi D Visvanathan; Chorong Park; Jolaade Kalinowski; Hua Zhong; Jeffrey S Berger; Judith S Hochman; Glenn I Fishman; Gbenga Ogedegbe
Journal:  Am Heart J       Date:  2018-04-21       Impact factor: 4.749

2.  For Whom Does Mindfulness-Based Stress Reduction Work? Moderating Effects of Personality.

Authors:  Ivan Nyklíček; Mona Irrmischer
Journal:  Mindfulness (N Y)       Date:  2017-02-15

3.  What works best for whom? Cognitive Behavior Therapy and Mindfulness-Based Cognitive Therapy for depressive symptoms in patients with diabetes.

Authors:  K Annika Tovote; Maya J Schroevers; Evelien Snippe; Paul M G Emmelkamp; Thera P Links; Robbert Sanderman; Joke Fleer
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

4.  More Purpose in Life and Less Novelty Seeking Predict Improvements in Self-Compassion During a Mindfulness-Based Intervention: The EXMIND Study.

Authors:  Mari Akase; Takeshi Terao; Nobuko Kawano; Akari Sakai; Koji Hatano; Masanao Shirahama; Hirofumi Hirakawa; Kentaro Kohno; Nobuyoshi Ishii
Journal:  Front Psychiatry       Date:  2020-04-03       Impact factor: 4.157

5.  Efficacy and Moderation of Mobile App-Based Programs for Mindfulness-Based Training, Self-Compassion Training, and Cognitive Behavioral Psychoeducation on Mental Health: Randomized Controlled Noninferiority Trial.

Authors:  Winnie Ws Mak; Alan Cy Tong; Sindy Yc Yip; Wacy Ws Lui; Floria Hn Chio; Amy Ty Chan; Celia Cy Wong
Journal:  JMIR Ment Health       Date:  2018-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.